Latest News | Bain Capital Sells 2.4 Pc Stake in Emcure Pharma for Rs 563 Cr

Get latest articles and stories on Latest News at LatestLY. Global investment firm Bain Capital on Friday divested a 2.4 per cent stake in Emcure Pharmaceuticals for Rs 563 crore through an open market transaction.

New Delhi, Jul 4 (PTI) Global investment firm Bain Capital on Friday divested a 2.4 per cent stake in Emcure Pharmaceuticals for Rs 563 crore through an open market transaction.

Following the stake sale, shares of Emcure Pharmaceuticals slipped 2.34 per cent to close at Rs 1,249.90 apiece on the NSE.

Also Read | Bodoland Lottery Result Today, July 04, 2025: Assam State Lottery Sambad Friday Lucky Draw Results Declared, Check Winners List With Ticket Numbers.

US-based Bain Capital through its BC Investments IV sold 45 lakh shares or 2.37 per cent stake in Emcure Pharmaceuticals, as per the bulk deal data on the National Stock Exchange (NSE).

The shares were disposed of at an average price of Rs 1,250.44 apiece, taking the transaction value to Rs 562.70 crore.

Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for July 04, 2025 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game.

After the latest transaction, Bain Capital's shareholding in Emcure has come down to 6.31 per cent from 8.68 per cent.

Details of the buyers of Emcure Pharmaceuticals' shares could not be ascertained on the exchange.

In May, Emcure reported a 63 per cent rise in consolidated profit after tax (PAT) to Rs 197 crore during the March quarter.

It reported a PAT of Rs 121 crore on a consolidated basis a year ago.

During the January-March period, Emcure Pharmaceuticals' revenue from operations stood at Rs 2,116 crore, up 19.5 per cent year-on-year from Rs 1,771 crore.

Emcure's domestic business grew 24.8 per cent year-on-year, led by its women's health and cardio franchises. Meanwhile, the international business registered a growth of 15.6 per cent.

In July last year, Emcure's IPO received a stellar response from institutional buyers by garnering 67.87 times subscription.

Pune-based Emcure Pharmceuticals is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now